An Independent FDA: An Idea Whose Time Is Still Coming
This article was originally published in The Gray Sheet
Executive Summary
Despite strong support from six former agency commissioners, the notion of an FDA that is independent from HHS is likely to remain theoretical, at least for the near term.
You may also be interested in...
HHS Overrules FDA On Plan B OTC, Sends Teva Back To Drawing Board
HHS Secretary Sebelius’ override appears to set a precedent of HHS intervention in an FDA product review.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.